{"id":"NCT01112865","sponsor":"Pfizer","briefTitle":"Cross Over Convenience And Preference Study Of New Mark VII Compared To Genotropin Pen In Pediatric And Adult Subjects","officialTitle":"A Multicenter, Open-label, Randomized Two Arm Cross Over Study Assessing Dyad (Subject and Caregiver) and Adult Subject Perception of Convenience and Preference of the Newly Developed Genotropin Mark VII Pen.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-08","primaryCompletion":"2011-10","completion":"2011-10","firstPosted":"2010-04-28","resultsPosted":"2012-05-14","lastUpdate":"2012-05-22"},"enrollment":120,"design":{"allocation":"RANDOMIZED","model":"CROSSOVER","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Growth Hormone Deficiency"],"interventions":[{"type":"DEVICE","name":"Genotropin Pen","otherNames":[]},{"type":"DEVICE","name":"MARK VII pen","otherNames":[]},{"type":"DEVICE","name":"Genotropin Pen","otherNames":[]},{"type":"DEVICE","name":"MARK VII pen","otherNames":[]}],"arms":[{"label":"Mark VII/Current pen","type":"OTHER"},{"label":"Current pen/Mark VII","type":"OTHER"}],"summary":"Convenience and preference for the new Mark VII pen compared to the current Genotropin pen will be assessed using a questionaire. it is expected that the new pen will be preferred or at least no different to the current pen.","primaryOutcome":{"measure":"Percentage of Dyads (Participant and Caregiver or Parent) and Adult Participants Reporting no Difference or Easier to Use for the New Genotropin Mark VII Injection Pen Compared to the Genotropin Pen®","timeFrame":"Month 4","effectByArm":[{"arm":"Entire Study Population","deltaMin":67.23,"sd":null}],"pValues":[]},"eligibility":{"minAge":"4 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":3},"locations":{"siteCount":23,"countries":["Czechia","Germany","Netherlands","Slovakia","Sweden","Turkey (Türkiye)","United Kingdom"]},"refs":{"pmids":["24748824"],"seeAlso":["https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=A6281297&StudyName=Cross%20Over%20Convenience%20And%20Preference%20Study%20Of%20New%20Mark%20VII%20Compared%20To%20Genotropin%20Pen%20In%20Pediatric%20And%20Adult%20Subjects"]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":120},"commonTop":["Headache","Nasopharyngitis","Viral infection","Injection site injury","Injection site pain"]}}